Ampio Pharmaceuticals develops innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction. The company’s product pipeline includes new uses for previously approved drugs and new molecular entities. Its growth strategy includes actively exploring partnership, licensing and other collaboration opportunities. For more information visit the company’s Web site at: www.ampiopharma.com.

Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. For more information on Aegis Capital, visit www.aegiscapcorp.com.

Let us hear your thoughts below: